Clindamycin Palmitate Hydrochloride For Oral Solution…

Date

Aug. 19, 2026

Risk class

Class II (FDA's definition, 21 CFR 7.3(m): a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote)

Status

Ongoing

Filed by

Heritage Pharmaceuticals Inc

Product

CLINDAMYCIN PALMITATE HYDROCHLORIDE FOR ORAL SOLUTION, USP, 75 mg/5 mL, Rx Only, 100 mL, Distributed by: Avet Pharmaceuticals Inc., East Brunswick, NJ 08816, NDC 23155-603-51

Reason

Presence of Foreign Substance: presence of particles and white flakes in the reconstituted bottles.

Distribution pattern

Nationwide within the U.S

Codes and lots

Lot #: 2411550, Exp. 2026/NOV.

Recall started

July 30, 2026

Recall number

D-0768-2026

What should I do? Medicine recall: what to do

Source: FDA · Drug enforcement report, recall number D-0768-2026. The agency record governs; check it and the company before acting.